Crystallization and preliminary crystallographic analysis of the bacterial capsule assembly-regulating tyrosine phosphatases Wzb of Escherichia coli and Cps4B of Streptococcus pneumoniae by Huang, Hexian et al.
crystallization communications
770 doi:10.1107/S1744309109023914 Acta Cryst. (2009). F65, 770–772
Acta Crystallographica Section F
Structural Biology
and Crystallization
Communications
ISSN 1744-3091
Crystallization and preliminary crystallographic
analysis of the bacterial capsule assembly-regulating
tyrosine phosphatases Wzb of Escherichia coli and
Cps4B of Streptococcus pneumoniae
Hexian Huang,
a‡ Gregor
Hagelueken,
a‡ Chris Whitfield
b
and James H. Naismith
a*
aCentre for Biomolecular Sciences,
The University of St Andrews, Fife KY16 9RH,
Scotland, and
bDepartment of Molecular and
Cellular Biology, University of Guelph,
Ontario N1G 2W1, Canada
‡ These authors contributed equally.
Correspondence e-mail:
naismith@st-andrews.ac.uk
Received 15 May 2009
Accepted 22 June 2009
Bacterial tyrosine kinases and their cognate phosphatases are key players in the
regulation of capsule assembly and thus are important virulence determinants of
these bacteria. Examples of the kinase/phosphatase pairing are found in Gram-
negative bacteria such as Escherichia coli (Wzc and Wzb) and in Gram-positive
bacteria such as Streptococcus pneumoniae (CpsCD and CpsB). Although Wzb
and Cps4B are both predicted to dephosphorylate the C-terminal tyrosine
cluster of their cognate tyrosine kinase, they appear on the basis of protein
sequence to belong to quite different enzyme classes. Recombinant puriﬁed
proteins Cps4B of S. pneumoniae TIGR4 and Wzb of E. coli K-30 have been
crystallized. Wzb crystals belonged to space-group family P3x21 and diffracted
to 2.7 A ˚ resolution. Crystal form I of Cps4B belonged to space-group family
P4x212 and diffracted to 2.8 A ˚ resolution; crystal form II belonged to space
group P212121 and diffracted to 1.9 A ˚ resolution.
1. Introduction
Gram-negative and Gram-positive pathogens often utilize capsules to
evade and resist the immune system (Whitﬁeld, 2006). Capsules are
formed from carbohydrate polymers which are known as capsular
polysaccharides (CPS) and form a discrete layer that covers the cell
surface. Although there are several CPS biosynthesis systems, argu-
ably the most widespread is the well studied Wzy carbohydrate
polymerase-dependent pathway found in many Gram-positive and
Gram-negative bacteria (Whitﬁeld, 2006; Grangeasse et al., 2007;
Cuthbertson et al., 2009). In the Wzy-dependent system, there is a
requirement for both a tyrosine autokinase and a cognate phospha-
tase, and the available evidence suggests that the cycling of the
phosphorylation state is crucial to the synthesis and export of CPS.
Wzc from Escherichia coli and CpsCD Streptococcus pneumoniae are
members of the tyrosine BY kinase family and are dephosphorylated
by the phosphatases Wzb and CpsB, respectively (Grangeasse et al.,
2007).
Although the two phosphatases essentially catalyse the same
reaction, Wzb and CpsB share no meaningful sequence identity and
in fact belong to separate enzyme families. The NMR structure of
Wzb (Lescop et al., 2006) conﬁrmed that it belongs to the low-
molecular-weight protein tyrosine phosphatases (LMW-PTPs), which
occur in both prokaryotes and eukaryotes (Grangeasse et al., 2007).
LMW-PTPs use a conserved cysteine nucleophile that generates an
enzyme-bound thiophosphate ester intermediate, thereby liberating
the tyrosine. The intermediate is then resolved in a second step by a
water molecule (Ramponi & Stefani, 1997). CpsB phosphatases
belong to the polymerase and histidinol phosphatase (PHP) family
(Aravind & Koonin, 1998) and unlike Wzb they appear to be metal-
dependent (Morona et al., 2002; Mijakovic et al., 2005; LaPointe et al.,
2008). No structural information for CpsB-like phosphatases is
currently available. We wish tounderstand how these clearly different
enzymes catalyse the same reaction and in doing so how they
recognize the substrate. Capsule assembly is a potential therapeutic
target and as the phosphatases are essential to this, a structural
understanding of the phosphatases may offer a basis for rational drug
design.2. Expression and purification
The cps4b gene from S. pneumoniae TIGR4 was ampliﬁed from
genomic DNA by PCR using the following oligonucleotides:
cps4bfwd, 50-GGC GGC CCATGG GCATGATAG ACATCCATT
CGC ATA TCG-30, and cps4brev, 50-GCC GCC GTC GAC CTA
AAT TAG TTG ATC CAT TAC AAT TTT TCG-30. The PCR
product was cloned into the pEHISTEV vector (Liu & Naismith,
2009). Plasmid pWQ145 contains the wzb gene cloned in pET28a(+)
and details of the construct have been described elsewhere (Wuge-
ditsch et al., 2001). Both constructs have an N-terminal His tag and
the cps4b construct contains an additional tobacco etch virus (TEV)
cleavage site between the His tag and the protein-coding sequence.
An identical expression and puriﬁcation procedure was followed for
both proteins. The plasmids were transformed into E. coli Rosetta
cells. Asingle colony was selected and grown overnight in Luria broth
(LB) medium containing 50 mgm l
 1 kanamycin and 37 mgm l
 1
chloramphenicol. The overnight culture was used to inoculate 5 l LB
medium at a ratio of 1:100. This culture was then grown at 310 K with
shaking at 200 rev min
 1. Once the culture had reached an optical
density (600 nm) of 0.4, the incubation temperature was lowered to
288 K. At an OD600 of  1.0, protein expression was induced by
adding isopropyl -d-1-thiogalactopyranoside (IPTG) to a ﬁnal
concentration of 1 mM and the culture was incubated at 288 K
overnight. Cells were harvested by centrifugation at 7000g for 30 min.
Cell pellets containing the target proteins were resuspended in lysis
buffer (20 mM phosphate pH 7.0) containing Benzonase (20 mgm l
 1;
Sigma) and Complete protease-inhibitor cocktail tablets (Roche
Diagnostics; one tablet per 50 ml extract) and the mixture was stirred
at 277 K for 30 min. A cell disrupter (207 MPa; Constant Cell
Disruption Systems, Daventry, England) was used to disrupt the cells
and the lysate was clariﬁed by centrifugation at 30 000g for 1 h at
277 K. The cell-free supernatant was incubated with Ni–NTA resin
(Sigma HIS-Select HF Nickel Afﬁnity Gel) for 1 h at 277 K. Prior to
loading, the resin was equilibrated in lysis buffer containing 100 mM
NaCl. The loaded resin was washed with buffer A (50 mM Tris–HCl
pH8, 100 mM NaCl) containing 50 mM imidazole and the target
proteins were eluted with buffer A containing 500 mM imidazole. For
Wzb, 5 mM dithiothreitol (DTT, ﬁnal concentration) was added to
the eluted protein. The Cps4B protein was incubated with 5 mg TEV
protease overnight at 277 K. The protease and uncleaved protein
were removed by a second metal-afﬁnity column. For ﬁnal puriﬁca-
tion, the proteins were passed over a Superdex 200 16/60 column (GE
Healthcare) and eluted with buffer A (containing 5 mM DTT for
Wzb). Fractions with appropriate purity as judged by SDS–PAGE
were pooled and concentrated to 10 mg ml
 1 for crystallization.
Protein identity and integrity were conﬁrmed by mass spectrometry.
The proteins were ﬂash-frozen in liquid N2 using thin-walled PCR
tubes and stored at 193 K prior to further use.
3. Crystallization
Initial crystallization trials for Wzb and Cps4B were performed using
a Honeybee 963 robot system (Genomic Solutions) and the following
commercially available crystallization screens: JCSG+ and pHClear
from Nextal, Classics and PEG/Ion from Hampton Research and
Cryo II and Wizard from Emerald BioSystems. For each of the
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Figure 1
Crystals (upper panels) and the corresponding diffraction patterns (lower panels) of (a) Wzb (space group P3x21), (b) Cps4B crystal form I (space group P4x212) and (c)
Cps4B crystal form II (space group P212121).96-well sitting-drop vapour-diffusion screens (MRC plates, Wilden),
150 nl protein solution was mixed with 150 nl precipitant and equi-
librated against a reservoir of 75 ml precipitant. The sealed plates
were then incubated at 293 K.
Initial Wzb crystals were obtained in condition B7 of the PEG/Ion
Screen HT (Hampton Research) and were further optimized by
several rounds of 24-well format hanging-drop experiments in which
the precipitant concentration and pH were varied. The best results, as
judged by crystal appearance, were obtained by mixing 1 ml protein
solution (17 mg ml
 1) with 1 ml well solution consisting of 0.2 M
K2HPO4, 18%(w/v) PEG 3350, 0.1 M Tris–HCl pH 8.0. Crystals
appeared after 1 d at 293 K (Fig. 1a). Prior to ﬂash-freezing in liquid
nitrogen for data collection, the crystals were cryoprotected by
transferring them to a cryosolution consisting of crystallization
mother liquor supplemented with 15% glycerol.
Cps4B crystallized in two different crystal forms [crystal form I
using condition No. 4 of Crystal Screen (Hampton Research); crystal
form II using condition No. 38 of Cryo II (Emerald BioSystems);
Figs. 1b and 1c]. Again, several rounds of hanging-drop optimization
experiments were required to improve the initial crystallization
conditions. Optimized crystals of form I were obtained by mixing 1 ml
protein solution (10 mg ml
 1) with 1 ml well solution (2 Mammonium
sulfate, 0.1 M Tris–HCl pH 8.5). Crystals of form I appeared after 2 h
at 293 K. The crystals were cryoprotected with crystallization mother
liquor supplemented with 20% glycerol. Optimized crystals of form II
were obtained by mixing 1 ml protein solution (10 mg ml
 1)w i t h1ml
well solution [0.1 M sodium acetate, 35%(w/v) PEG 400 pH 4.2] and
appeared after two weeks at 293 K. Cryoprotection was not necessary
for crystal form II.
4. Preliminary crystallographic characterization
The Wzb crystals diffracted to 2.7 A ˚ resolution. A single crystal was
used to collect X-ray diffraction data over a range of 150  (0.5  steps)
on the IO2 beamline ( = 0.9796 A ˚ ) at the Diamond Light Source
(Didcot, England), which is equipped with an ADSC Q315 detector.
The data were indexed and processed in the trigonal space-group
family P3x21 using HKL-2000 (Otwinowski & Minor, 1997). Data-
collection statistics are shown in Table 1. Assuming a reasonable
solvent content of 58%, the asymmetric unit of the Wzb crystals
contains two Wzb monomers, corresponding to a Matthews coefﬁ-
cient of 2.94 A ˚ 3 Da
 1. MOLREP from the CCP4 suite was used to
calculate a self-rotation function (Collaborative Computational
Project, Number, 1994). The  = 180  section did not reveal any clear-
cut noncrystallographic twofold axis. Thus, if the asymmetric unit
indeed contains two Wzb molecules they are either not related by a
twofold axis or the latter is parallel to one of the crystallographic
twofold axes. In gel-ﬁltration experiments Wzb elutes as a monomeric
protein, indicating that the possible dimer in the asymmetric unit of
the Wzb crystals is not functionally relevant. We expect to solve the
structure of Wzb by molecular replacement using an NMR model of
Wzb from E. coli K-12 (Lescop et al., 2006). The K-30 and K-12 Wzb
homologues share 51% identical amino acids.
Cps4B crystals of crystal form I belonged to the space-group family
P4x212 and diffracted to 2.8 A ˚ resolution. In contrast, crystals of form
II belonged to the orthorhombic space group P212121 and diffracted
to >1.9 A ˚ resolution. In both cases a single crystal was used to collect
X-ray diffraction data over a range of 180  in steps of 0.25  using
Cu K radiation on a Rigaku Saturn 944 detector. The data were
indexed and processed using the program XDS (Kabsch, 1988). The
data-collection statistics for both crystal forms are listed in Table 1.
As judged by the calculation of Matthews coefﬁcients (P4x212,
3.2 A ˚ 3 Da
 1; P212121,2 . 6 0A ˚ 3 Da
 1), both crystal forms contained a
single molecule of Cps4B per asymmetric unit. Since the PDB data-
base does not contain a suitable model that could be exploited to
solve the Cps4B structure by molecular replacement, our efforts are
now focused on gaining experimental phases for the Cps4B crystals.
The work was supported by a Wellcome Trust Program Grant
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Table 1
Experimental X-ray data.
Values in parentheses are for the highest resolution shell.
Cps4B
Wzb Crystal form I Crystal form II
Space group P3x21 P4x212 P212121
Crystal system Trigonal Tetragonal Orthorhombic
Unit-cell parameters
(A ˚ ,  )
a = 90.0, b = 90.0,
c = 83.5,
 =  = 90,
 = 120
a = 89.5, b = 89.5,
c = 91.7,
 =  =  =9 0
a = 44.0, b = 58.5,
c = 114.8,
 =  =  =9 0
Matthews coefﬁcient
(A ˚ 3 Da
 1)
2.94 3.21 2.60
Molecules per ASU 2 1 1
Resolution range (A ˚ ) 50.0–2.74 30.0–2.8 30.0–1.91
Mosaicity ( ) 0.5 0.2 0.1
Total observations 92428 64805 202027
Unique reﬂections 10664 17410 40850
Completeness (%) 99.4 (100) 98.5 (85.1) 92.5 (61.4)
Rmerge (%) 7.0 (45.5) 11.9 (46.4) 1.9 (4.4)
Multiplicity 8.7 3.7 5.0
I/(I) 27.3 (5.4) 14.3 (4.2) 64.4 (27.8)